Knowledge about and attitude toward cosmeceuticals among pharmacists in Saudi Arabia

被引:3
作者
Almeman, Ahmad A. [1 ]
机构
[1] Qassim Univ, Dept Pharmacol & Therapeut, Coll Med, Buraydah, Saudi Arabia
关键词
knowledge; pharmacists; Saudi Arabia; skin bleaching; whitening cosmeceuticals; UNIVERSITY-STUDENTS; KOJIC ACID; SKIN; SAFETY; COMBINATION;
D O I
10.1111/jocd.13358
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Whitening cosmeceuticals are commonly used for beauty purposes and managing pigmentation disorders. There is significant variability across the world with regard to knowledge as well as legislation of cosmeceuticals. Aim To evaluate the knowledge of and attitude toward whitening cosmeceuticals among pharmacists in Saudi Arabia. Methods This was a descriptive cross-sectional observational study based on an online survey conducted between February and August 2019. The participants were registered pharmacists in different sectors in Saudi Arabia. The study was approved by the Ethics Committee of Qassim, Ministry of Health. The pharmacists' response to questions on demographic characteristics, occupation, knowledge, and attitude toward whitening cosmeceuticals were collected in an online sheet. Results In all, 584 pharmacists completed the survey; of these, 5.49%, 24.82%, and 70% were consultants, pharmacists I, and pharmacists, respectively. The male-to-female ratio was 1.6:1. The most common response in the survey is "I don't know." Interestingly, 324 (59.12%) of the participants could define whitening cosmeceuticals, but 520 (90%) did not identify the term's source. Regarding practice, 196 (35.77%) participants had never used a whitening cosmetic, whereas 72 (13.14%) had but could not identify the agent. Forty percent of the participants were unaware of the possibility of combining two or more whitening cosmeceuticals and 13.14% thought that such combinations are contraindicated. Conclusion There is significant variability among pharmacists in Saudi Arabia regarding the understanding and practice of whitening cosmeceuticals. Our results indicate that further measures are essential for increasing the awareness of pharmacists in Saudi Arabia.
引用
收藏
页码:2946 / 2952
页数:7
相关论文
共 32 条
  • [1] Cosmetic Regulation and Alternatives to Animal Experimentation in India
    Akbarsha, Mohammad A.
    Mascarenhas, Benedict
    [J]. ALTERNATIVES TO ANIMAL TESTING, 2019, : 57 - 62
  • [2] Alanzi ME, 2018, J COSMET SCI, V69, P101
  • [3] Cosmeceuticals versus pharmaceuticals
    Amer, Mohamed
    Maged, Mina
    [J]. CLINICS IN DERMATOLOGY, 2009, 27 (05) : 428 - 430
  • [4] [Anonymous], 2019, SFDA PRODUCTS CLASSI
  • [5] Cosmeceuticals in skin of color
    Baumann, Leslie
    [J]. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2016, 35 (04) : 233 - 237
  • [6] DeoxyArbutin:: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency
    Boissy, RE
    Visscher, M
    deLong, MA
    [J]. EXPERIMENTAL DERMATOLOGY, 2005, 14 (08) : 601 - 608
  • [7] Cosmeceuticals: Current Trends and Market Analysis
    Brandt, Fredric S.
    Cazzaniga, Alex
    Hann, Michael
    [J]. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2011, 30 (03) : 141 - 143
  • [8] Final Report of the Safety Assessment of Kojic Acid as Used in Cosmetics
    Burnett, Christina L.
    Bergfeld, Wilma F.
    Belsito, Donald V.
    Hill, Ronald A.
    Klaassen, Curtis D.
    Liebler, Daniel C.
    Marks, James G., Jr.
    Shank, Ronald C.
    Slaga, Thomas J.
    Snyder, Paul W.
    Andersen, F. Alan
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2010, 29 : 244S - 273S
  • [9] Effects of vitamin C vs. multivitamin on melanogenesis: comparative study in vitro and in vivo
    Choi, Yang Kyu
    Rho, Yong Kwan
    Yoo, Kwang Ho
    Lim, Yun Young
    Li, Kapsok
    Kim, Beom Joon
    Seo, Seong Jun
    Kim, Myeung Nam
    Hong, Chang Kwun
    Kim, Dong-Seok
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (02) : 218 - 226
  • [10] Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on the safety of the use of α-arbutin in cosmetic products
    Degen, Gisela H.
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2016, 74 : 75 - 76